Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

Outcomes from the medication assisted treatment pilot program for adults with opioid use disorders in rural Colorado

As Colorado ranked among the top nationally in non-medical use of opioids, a pilot medication for opioid use disorder (MOUD) program was developed to increase the number of NPs and PAs providing MOUD

Original research | 2022

Evidence base, Safer supply, About PWUD, Outcomes, Chronic pain, Mental health

Peer Connect BC

Webpage | 2021

Peer/PWLLE program involvement

Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?

Cocaine use contines to be a significant public health problem world-wide.

Commentary | 2020

Illegal drugs, Stimulants

Practitioners’ views on shared decision-making implementation: A qualitative study

Shared decision-making (SDM) refers to the collaboration between patients and their healthcare providers to make clinical decisions based on evidence and patient preferences, often supported by patien

Original research | 2021

Hesitancy of prescribers , About prescribers, Hospitals

Prevalence and risk factors for opioid related mortality among probation clients in an American city

Substance use disorder researchers and treatment professionals have long recognized that risk of opioid-related mortality (ORM) is elevated after release from jail and prison.

Original research | 2021

Overdose, Mortality, Equity, About PWUD, Social services, Outcomes, Legal system/law enforcement, Illegal drugs

Reducing the stigma surrounding opioid use disorder: evaluating an opioid overdose prevention training program applied to a diverse population

To evaluate the effectiveness of an innovative opioid overdose prevention program (OOPP), with changes in knowledge and attitudes serving as the primary outcome measures.

Original research | 2022

Overdose, Harm reduction, About prescribers, Stigma

“In their mind, they always felt less than”: The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention

One known barrier to MOUD retention is stigma, particularly within ethno-racial minority communities.

Original research | 2022

About PWUD, Barriers and enablers, Substitution/OAT, Peer/PWLLE program involvement, Stigma

Healthcare seeking among Swedish patients in opioid substitution treatment – a mixed methods study on barriers and facilitators

Barriers to, and facilitators of, OST patients’ healthcare seeking have been sparsely examined.

Original research | 2022

Wrap-around services, Barriers and enablers, About PWUD, Substitution/OAT, Stigma

Assessing the feasibility, acceptability and accessibility of a peer-delivered intervention to reduce harm and improve the well-being of people who experience homelessness with problem substance use: the SHARPS study

The study used mixed methods to assess the feasibility, acceptability and accessibility of a peer-delivered, relational intervention to reduce harms and improve health/well-being, quality of life a

Original research | 2022

Peer/PWLLE program involvement, Wrap-around services

The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19

This study aimed to identify barriers and facilitators of implementing drug checking services with spectrometry devices in an urban harm reduction organization and syringe service program serving e

Original research | 2022

Harm reduction, Wrap-around services, Drug checking, Legal system/law enforcement

The details of decriminalization: Designing a non-criminal response to the possession of drugs for personal use

Commentary | 2022

Policy/Regulatory, Equity, Decriminalization/legalization

Prescribed opioid analgesics in early pregnancy and the risk of congenital anomalies: a population-based cohort study

We sought to further quantify the risk of anomalies after opioid analgesic exposure during the first trimester in a population-based cohort study.

Original research | 2022

Sex/Gender , Illegal drugs, About PWUD, Parents/caregivers

Youth substance use service provider’s perspectives on use and service access in ontario: time to reframe the discourse

In Ontario, Canada, substance use is common among youth, yet treatment is underutilized, suggesting the potential for an unmet need in terms of substance use care.

Original research | 2022

Social services, Youth, Stigma

Implementation of a nurse-led overdose prevention site in a hospital setting: lessons learned from St. Paul’s Hospital, Vancouver, Canada

St. Paul's Hospital opened a nurse-led OPS in February 2021. This paper describes the steps leading to the implementation of the nurse-led OPS, its impact, and lessons learned.

Original research | 2022

Hospitals, SCS/OPS, Illegal drugs, Wrap-around services, Harm reduction, Overdose

Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada

We aimed to identify and characterize patients receiving safer supply immediate-release hydromorphone (IRH) and their prescribers in Ontario.

Original research | 2022

Evidence base, Safer supply, Advocacy, About PWUD, Outcomes, Mortality, Transitions in care/treatment

Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey

Describing substance use practices and elucidating correlates of concurrent use can inform harm reduction service provision and prevent overdose events.

Original research | 2022

Overdose, Policy/Regulatory, About PWUD, Youth, Illegal drugs, Stimulants

META:PHI Withdrawal Management Services Manual

This manual was created for providers working in residential community-based withdrawal management services (WMS) to standardize care, improve documentation and information sharing, and provide qui

Webpage | 2021

Withdrawal, About prescribers, Illegal drugs, Substitution/OAT, Stimulants, Harm reduction, Safer supply

Nouveaux opioïdes synthétiques autres que le fentanyl : Évaluation des risques et conséquences pour la pratique

Étant donné la nécessité d'une intervention efficace du système de santé pour réduire les méfaits liés aux substances, il est important d'examiner l'impact potentiel des nouveaux opioïdes synthétiq

Rapport | 2021

les drogues illégales, les services d'analyse de drogues, la réduction des méfaits

Novel Non-Fentanyl Synthetic Opioids: Risk Assessment and Implications for Practice

Given the need for effective responses of the health system to reduce substance-related harms, it is important to consider the potential impact of novel non-fentanyl synthetic opioids on opioid-rel

Report | 2021

Illegal drugs, Drug checking, Harm reduction